Caxton Associates (New York)’s Karyopharm Therapeutics KPTI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-15,708	Closed	-$917K	–	574
2023 Q1	$917K	Buy	15,708 +10,646	+210%	+$621K	0.14%	157
2022 Q4	$258K	Buy	5,062 +268	+6%	+$13.7K	0.02%	331
2022 Q3	$393K	Buy	4,794 +1,394	+41%	+$114K	0.05%	267
2022 Q2	$230K	Buy	+3,400	New	+$230K	0.02%	427